Rebecca Lim, PhD profile page

Dr. Rebecca Lim is chief scientific officer at INOVIQ Ltd (ASX: IIQ), where she leads scientific and development strategy for the company’s extracellular vesicle(EV)–based diagnostics and therapeutics programs. She has more than two decades of experience translating cell, gene, and EV technologies from discovery through clinical development. Before joining INOVIQ, Rebecca held senior roles at CTMC and Prescient Therapeutics, and research appointments at Monash University and the Hudson Institute of Medical Research.. She has authored more than 100 peer-reviewed publications, is an inventor on several patents, and has led multidisciplinary programs spanning preclinical development through to first-in-human translation.